3M Healthcare - Facilities in the U.S. and Asia ramped up production of N95 respirator mask and other protective gear, placing reserve equipment into production and adding additional staff and overtime shifts. 

Abbott Laboratories - received emergency use approval from the U.S. Food and Drug Administration for its rapid COVID-19 test has already begun the process of distributing enough devices and COVID-19 test cartridges to enable 50,000 tests per day.  

Becton Dickinson and Co - partnered with diagnostics company BioMedomics to produce a diagnostic test that can detect current or past exposure to the coronavirus within minutes and can be used in doctors' offices and other settings.

Berlin Packaging - creating COVID-19 test kits.

BMS/Celgene – conducting clinical trials of vaccines.

DiaSorin S.p.A - immediately initiated an R&D project to develop a rapid molecular kit to detect the COVID-19 in swabs.

GE Healthcare - partnering with Ford to produce 50,000 ventilators in the next 100 days - with plans to ramp up with about 1,500 ventilators by end of April, reaching 7,200 vents/week over the next few months.   

Gilead Sciences’ - their antiviral drug, Remdesivir, is the leading drug among existing Covid-19 therapy projects and is currently used in a phase 3 trial on over 1,000 patients worldwide. Taking steps to quickly ramp production should Remdesivir prove to be a safe and effective for the treatment of Covid-19. 

GM - re-opened a plant in Warren, Michigan to make Level 1 surgical masks in response to the demand for more face masks across the U.S. They also have plans to produce ventilators at their engine plant in Kokomo, Indiana with partner Ventec Life Systems.

Hologic - received FDA emergency use authorization for a molecular test for the novel coronavirus, SARS-CoV-2 - manufacturing 600,000 kits per month.

Johnson & Johnson - committing more than $1 billion to research and development toward development of a vaccine for Covid-19.

Janssen Pharmaceutical - a division of Johnson & Johnson, is also working with researchers at Beth Israel Deaconess Medical Center and expects to begin Phase 1 Human clinical studies of its vaccine candidate by September 2020.

McKesson - working with FEMA to ensure critical supplies reach hardest hit locations. 

Medtronic - sharing full design specifications for its Puritan Bennett (PB) 560 portable ventilator hardware to enable other manufacturers to rapidly increase ventilator production.

P&G – increasing production and donating face masks and hand sanitizer to hospitals, health authorities and relief organizations.

Phillips Respironics - ramped production up for ventilator manufacturing lines to help meet demand.

Stryker - developed & released emergency relief beds in seven days-time and committed to continuing the effort and manufacturing 10,000 beds per week.

Thermo Fisher Scientific – developing diagnostic kits for COVID-19.

Thomas Scientific - prioritizing shipping lines for PPE equipment and searching for additional supply lines.

Walgreens – has increased demand for fulfilling online orders.